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Abstract
Background: Codon usage differences are known to regulate the levels of gene expression in a
species-specific manner, with the primary factors often cited to be mRNA processing and
accumulation. We have challenged this conclusion by expressing the human acetylcholinesterase
coding sequence in transgenic plants in its native GC-rich sequence and compared to a matched
sequence with (dicotyledonous) plant-optimized codon usage and a lower GC content.
Results: We demonstrate a 5 to 10 fold increase in accumulation levels of the "synaptic" splice
variant of human acetylcholinesterase in Nicotiana benthamiana plants expressing the optimized
gene as compared to the native human sequence. Both transient expression assays and stable
transformants demonstrated conspicuously increased accumulation levels. Importantly, we find
that the increase is not a result of increased levels of acetylcholinesterase mRNA, but rather its
facilitated translation, possibly due to the reduced energy required to unfold the sequence-
optimized mRNA.
Conclusion: Our findings demonstrate that codon usage differences may regulate gene expression
at different levels and anticipate translational control of acetylcholinesterase gene expression in its
native mammalian host as well.
Background
Different organisms preferentially use a different subset of
the synonymous codons specifying a certain amino acid.
In fact, codon usage is emerging as an important regula-
tory factor, and codon usage bias can be detected not only
between organisms [1], but also in the same organism
between differentially expressed genes [2], in different tis-
sues [3] and developmental stages [4]. A correlation was
found in some cases, most notably among prokaryotes
and in some metazoans (e.g. in dipterans and in nema-
todes), between the codon usage and the abundance of
the cognate tRNAs, indicating that in these cases at least
codon usage is probably governed by evolutionary selec-
tive forces [5-8]. However, "translational selection" may
not be the only adaptive process shaping codon usage,
which can be biased due to interactions not (directly)
involving codon-anticodon interactions such as splice-site
recognition [9] and mRNA turnover [10]. Particularly,
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while the available genome-scale analyses done for several
plant species demonstrate that codon bias in plants is
adaptive [11,12], heterologous gene expression studies in
plants led to a tentative conclusion that translation effi-
ciency of the foreign genes is often considered secondary
to mRNA processing and stability as a determinant for
expressivity [13].
For many reasons, acetylcholinesterase, (AChE) is a useful
model for a comparative study addressing the issue of
codon bias and translation efficiency, as well for post-
translational events [14,15]. Vertebrate genes encoding
the enzyme from several sources were expressed in a wide
variety of systems such as bacteria [16], yeast [17], mam-
malian cell cultures [18], transgenic mice [19] and more
recently in plants [20,21]. The enzyme is known for its
role in the termination of synaptic transmission by hydro-
lyzing acetylcholine, but during the past decade evidence
has been gathered indicating its critical role in various
processes such as development, stress responses, innate
immunity, and bioscavenging [14]. This complex array of
functions is enabled through the equally complex molec-
ular biology of the ACHE gene: the intricate control of its
transcription, alternative splicing and translation and the
equally intricate post-translational events governing its
function such as subcellular targeting, glycosylation, pro-
teolytic processing, membrane anchoring and protein-
protein interactions [14]. Interestingly, non-cholinergic
functions of AChE are underscored by identification of
AChE-like activity and genes potentially encoding the
enzyme in several plant species [21-23].
Original reports from our laboratory indicated that plants
can express this complex human enzyme. However, yields
of plant-expressed AChE were modest because of limita-
tions in the prototype expression construct and host plant
[20,21]. Here we demonstrate that AChE accumulation in
plants is limited at the translation stage and that the
enzyme levels can be dramatically increased as compared
to our previously reported results, by conforming its
codon usage and GC content to that of highly expressed
plant genes. The optimized sequence results in increased
translatability of the mRNA without affecting its accumu-
lation or processing.
Results
Design and cloning of the plant-expression optimized 
oACHE-S gene
More than a third of the codons of the human ACHE gene
(hACHE-S) are infrequently utilized in dicotyledonous
plants (i.e. as defined in the Methods section, they have
relative synonymous codon usage, RSCU, values of less
than 0.8, Fig. 1, Fig. 2, Table 1). Furthermore, a non-
canonical near-upstream element of a plant polyadenyla-
tion signal [24,25] (Fig. 2, Table 1) and two plant 5'-
intron splice signals with downstream 3'-splice signals
were identified in hACHES [26,27] (Fig. 2, Table 1). In
addition, potential methylation signals associated with
transcriptional silencing (CG and CNG) [28] are abun-
dant in the gene, reflecting its high GC content (65%, Fig.
1, Fig. 2, Table 1). Interestingly, the GC content in mid-
exonic regions is even higher, with peaks exceeding 75%
(Fig. 2). These regions are separated by deep troughs with
much lower GC content (<50%). In designing a plant-
expression optimized version of the gene, we took meas-
ures to correct for these potential problems. Thus, the rare
codons present in hACHE-S were changed in the synthetic
plant-expression optimized ACHE  gene (oACHES) to
more frequently used alternatives so that the codon adap-
tiveness index (CAI, for definition see the Methods sec-
tion) would match that of the most abundant nuclear-
encoded plant protein – the small subunit of ribulose
bisphosphate carboxylase (RuBisCO, Fig. 2 and Table 1).
Furthermore, the RNA processing signals were abolished,
most of the potential methylation signals were elimi-
nated, and the overall GC content was reduced to 55%,
much closer to the typical plant gene (Fig. 2, Table 1). In
particular, most of the GC content peaks were considera-
bly dampened. Please note that our optimization strategy
did not eliminate all infrequently used codons, giving
preference to the elimination of all other deleterious
sequences. However, the content of such (evenly distrib-
uted) codons was reduced to about 20% (similar to the
case of the RuBisCO small subunit, Fig. 2, Table 1). When
cloning hACHE-S and oACHE-S into plant expression vec-
tors, two minor changes in the amino acid sequence of the
encoded proteins were required due to the need to intro-
duce an NcoI site to facilitate the cloning (Fig. 1). These
deviations from the human sequence (R2A in hACHE-S
and insertion of G between M1 and R2 in oACHE-S) are
both in the cleavable signal peptide directing the protein
to the secretory pathway.
Optimization of transgene enhances AChE accumulation 
in plants
Binary expression vectors pTM245 and pTM092 encode
hACHE-S and oACHE-S, respectively (Fig. 3A). We com-
pared their expression in N. benthamiana leaves by Agro-
bacterium-mediated transient assay. In the hACHE-S-
infiltrated leaves AChE-S accumulated to 58 ± 3 mU/mg
protein, whereas the optimized sequence was expressed at
264 ± 40 mU/mg protein (mean ± SEM, Fig. 3B). Thus, the
accumulation level of the enzyme with the plant-expres-
sion optimized gene was about 5 fold higher than
obtained with the human sequence.
In optimizing the human ACHE-S gene sequence, we took
a preemptive approach: modifying many molecular fea-
tures that might have otherwise proven deleterious to the
expression of the transgene or to the accumulation of itsBMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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Sequence optimization of the hACHE-S gene Figure 1
Sequence optimization of the hACHE-S gene. Shown 
are the native (cDNA) human gene sequence (upper) and the 
optimized gene (lower). Nucleotide changes are shown, 
whereas unmodified nucleotides are represented by dashes. 
Above the two compared DNA sequences is the predicted 
amino-acid sequence of the AChE-S protein. Underline: 
potential methylation sites. Yellow box: infrequent plant 
codons. Red box: potential 5'-intron splice sites. Blue box: 
potential downstream 3'-intron splice sites. Purple box: a 
potential polyadenylation positional element. Please note that 
the only amino-acid deviations from the human cDNA are an 
R2A change in the human sequence and insertion of a G res-
idue on this position in the plant-optimized sequence. These 
changes were introduced to facilitate cloning into the plant 
expression vectors used in this study.
Comparison of the codon usage and GC content of hACHE-S  and oACHE-S Figure 2
Comparison of the codon usage and GC content of 
hACHE-S and oACHE-S. (A) Codon usage, expressed as a 
moving (window = 50 codons) geometric mean of the rela-
tive codon adaptiveness (w) was scored for hACHE-S (pink), 
oACHE-S (blue), and the highly-expressed plant gene rbcS 
(red). The CAI values of each (w averaged over the entire 
gene) are plotted as broken lines. Note that optimization 
increased the CAI value of the ACHE gene, bringing it close 
to the CAI value of the rbcS gene, which is even for this 
highly expressed gene lower than the theoretical maximal 
value of 1. (B) The GC content is scored for 100-base seg-
ments centering at each of the indicated bases of the hACHE 
and oACHE mRNA (taking into account the common TEV 
leader). Broken lines – the GC content of the entire coding 
regions.BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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product. Thus we have modified key signals leading to
transcriptional silencing (methylation), aberrant tran-
script processing (premature polyadenylation and unwar-
ranted splicing) and translation attenuation (codon
usage). It was therefore of interest to explore which of
these changes contributed to the dramatic improvement
in AChE accumulation observed with the optimized con-
struct. To this end we removed the two 5'-splice sites, the
potential poly-A site or all from the human sequence cre-
ating constructs pTM167, pTM165 and pTM164 respec-
tively. Conversely, we reintroduced the same sites into the
plant-expression optimized sequence, creating pTM195,
pTM197 and pTM156 respectively. These new AChE-
encoding plant expression constructs, alongside the
pTM092 and pTM049 were introduced into N. benthami-
ana by Agrobacterium-mediated gene transfer (Fig. 3C–E).
Because of the integration position effect, transformants
harboring the transgenes exhibited a range of recom-
binant gene expression levels, manifested in the distribu-
tion of AChE activities observed (Fig. 3D). Only
kanamycin-resistant plants that had detectable (non-zero)
AChE activity were considered for the following analyses.
Accumulation of AChE activity significantly differed (P <
0.0001) between plants expressing variants of hACHES
and plants expressing oACHES (and variants thereof). The
highest AChE activity level obtained among the hACHES
plants was 89 mU/mg protein, with a mean of 20 ± 3 mU/
mg protein (n = 47, Fig. 3C). These results are somewhat
higher but comparable to results previously described by
us regarding the expression of the non-optimized
sequence encoding the catalytic core of the enzyme in
tomato plants [20]. In sharp contrast, the highest specific
activity level demonstrated for oACHES plants was 852 ±
28 mU/mg protein and the observed mean was 129 ± 22
mU/mg protein (n = 75, Fig. 3C).
Optimization of transgene enhances AChE accumulation in  plants Figure 3
Optimization of transgene enhances AChE accumu-
lation in plants. (A) Plant expression cassettes used in this 
study. pTM245 driving the expression of hACHE-S. pTM092 
driving the expression of oACHE-S. pTM256 driving mosaic o-
hAChE-S. pTM257 driving the expression of mosaic h-oAChE-S. 
35S, CaMV 35S promoter; T, TEV leader; V, VSP terminator. 
Arrow heads, positions of oligonucleotides used in this for 
making probes, genomic PCR and RT-PCR (numbers refer to 
Table 2). (B) Transient expression assays in A. tumefaciens-
infiltrated leaves of N. benthamiana plants. 1, hACHE-S; 2, 
oACHES. Averages of 6 replicates (means ± SEM) are shown. 
(C) N. benthamiana plants were stably transformed to 
express (1) hACHE-S or (2) oACHE-S. Individual lines were 
screened at least 2 times. Averages of all lines (presented in 
Panel D) with detectible levels of AChE (means ± SEM) are 
shown. (D) AChE accumulation levels in individual genomic-
PCR positive plant lines expressing oACHE-S. Top inserts: 
AChE accumulation levels in individual plant lines expressing 
variants of hACHE-S: pTM167, pTM165 and pTM164. Bottom 
inserts: AChE accumulation levels in individual plant lines 
expressing variants of oACHE-S: pTM195, pTM197 and 
pTM156. Broken lines illustrate the maximal level of expres-
sion obtained with any of the hACHE-S lines. DNA fragments 
were PCR amplified from total DNA isolated from the indi-
cated plant lines with oACHE specific primers (oTM126 and 
oTM047) and were resolved by agarose gel electrophoresis 
(denoted PCR). (E) Cumulative frequency distribution of the 
AChE expression data of lines shown in Panel D (high to 
low) can be fitted with the following logarithmic regression 
equations: hACHE-S, y = -22.967Ln (x) + 107.63 (r2 = 0.90); 
oACHE-S: y = -15.013Ln (x) + 102.99 (r2= 0.98).
Table 1: Optimized molecular features.
Molecular Feature hACHE-S oACHE-S
Codon usagea
Uncommon 221 (36%) 89 (14%)
Other 393 (64%) 526 (86%))
Potential methylation sitesb
CG 110 0
CNG 192 82
Polyadenylation signalc
AATGGA 1 0
5'-intron splice signalsd
GTAAGT 1 0
GTACGT 1 0
GC content 64.9% 55.5%BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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The distribution of AChE accumulation data (Fig. 3E) is to
a good approximation lognormal, and can be fitted to a
logarithmic function, which allows one to predict the the-
oretical maximal level of AChE accumulation that may be
obtained with each of the construct families. These values
are in a good agreement with the actual observed maximal
values, being about 108 and 953 mU/mg protein for the
human and optimized constructs, respectively (Fig. 3E). It
therefore appears unlikely that by screening additional
transformants we could have identified hACHES lines that
would accumulate significantly higher levels of AChE,
than those we report. We conclude that expressing
oACHES constructs leads to a 10-fold increase in AChE
accumulation as compared to the hACHES constructs, and
that the enhancement is due to the sequence optimization
and not due to insufficient transformant pool size.
hACHE-S and oACHE-S transcripts accumulate to 
similar levels in transgenic plants
Our analysis of the human ACHE-S gene shows it contains
several plant RNA processing signals that theoretically
could lead to the production of truncated, presumably
inactive, AChE. However, removing these sequences in
hACHE-S  (pTM167, pTM165 and pTM164) or their
reintroduction into the oACHES  sequence (pTM195,
pTM197 and pTM156) did not have a considerable effect
on the enzyme accumulation levels (Fig. 3D). In contrast
to the highly significant difference between the two con-
struct families, no significant differences were found
among plants expressing variants of the hACHES
sequence (P > 0.12) or the one expressing variants of the
oACHES sequence (P > 0.07). This implies that the three
potentially deleterious sequences (the two 5'-intron splice
sites and the polyadenylation sequence) do not play a
major role in this case.
To corroborate this conclusion, we amplified by PCR
cDNA derived from either pTM050 (harboring hACHE-S
with a single base change) or pTM092 (oACHE-S) lines
using primers specific to the region encompassing the
potential introns. In both cases the only fragments ampli-
fied corresponded to the correct, full length, sequence
(Fig. 4A). Therefore, it seems unlikely that spurious splic-
ing events are responsible for the poor performance of the
hACHE-S construct. Similarly, an RNA blot analysis using
probes specific for the human vs. plant-expression opti-
mized sequences, demonstrated single, identically sized
transcripts in both hACHE-S  and  oACHE-S  of the pre-
dicted length (data not shown), abating the probability
that premature polyadenylation was limiting hACHE-S
expression as compared to oACHE-S.
Transcript accumulation levels and integrity were further
assayed by quantitative real-time PCR analysis using
primers and probes to either the 5'-UTR (TEV leader
Full-length hACHE-S and oACHE-S transcripts accumulate to  similar levels Figure 4
Full-length hACHE-S and oACHE-S transcripts accu-
mulate to similar levels. (A) RT-PCR amplification of 
ACHE transcript region potentially subjected to aberrant 
splicing. cDNA prepared from three lines of hACHE-S-R177W 
plants (1) and two lines of oACHE-S plants (2) were subjected 
to PCR amplification using the primers oTM089 and oTM049 
and then resolved by agarose gel electrophoresis. Primers 
were selected to amplify the region potentially subjected to 
alternative splicing. Unspliced transcripts are expected to 
yield 1.1 kb fragment. If either of the two potential 5'- and 3'-
intron splice sites were extensively utilized in plants harbor-
ing hACHE-S, shorter fragments of ~0.9 kb and ~0.5 kb are 
expected to be preferentially amplified. However, the full-
length species clearly dominates. (B-C) Correlation between 
ACHE transcript accumulation and AChE enzyme activity. 
Transcripts levels of optimized (pTM092) and non-optimized 
(pTM050) measured by quantitative real time RT-PCR and 
were scored relative to 18S rRNA. Probes were designed for 
the two common regions of the two types of ACHE tran-
scripts – (B) the 5'-UTR (TEV leader) and (C) the 3'-UTR 
(VSP terminator, upstream of the poly-A tail). Data obtained 
for multiple replicates was averaged and correlated with the 
respective AChE activity (normalized to the maximum level). 
When probed by the 5'-UTR probe, the correlation was 
highly significant with r2 = 0.72 (P < 0.0001) for the non-opti-
mized sequence and r2 = 0.61 (P = 0.0005) for the optimized 
sequence. When probed by the 3'-UTR probe, the correla-
tion was significant for the non-optimized sequence with r2 = 
0.48 (P = 0.0122) and highly significant with r2 = 0.49 (P < 
0.0001) for the optimized sequence. Inserts show scatter 
plots demonstrating the distribution of transcript levels in 
plants expressing hACHE-S and oACHE-S constructs. Each 
plant is depicted by a symbol and the mean ± S.D. are plot-
ted. The groups are not statistically different by an unpaired t 
test (5'-UTR probe: P > 0.45; 3'-UTR probe: P > 0.22).BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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sequence) or to the 3'-UTR (VSP terminator), common to
both hACHE-S and oACHE-S, and were normalized to the
co-determined levels of 18S rRNA. Normalized mRNA
levels were correlated with normalized AChE activity (Fig.
4B, 4C). For each construct, there exists a statistically sig-
nificant linear correlation between the accumulation lev-
els of AChE activity and those of ACHE transcripts when
assayed either with the TEV 5'-probe (hACHE-S: r2 = 0.73,
P = 0.0005; oACHE-S: r2 = 0.60, P <0.0001) or the VSP 3'-
probe (hACHE-S: r2 = 0.50, P = 0.0104; oACHE-S: r2 = 0.49,
P <0.0001). As expected, this suggests that for either type
of recombinant gene, the accumulation of the enzyme
product depends on the levels of its cognate mRNA, which
vary among the different plant lines for each construct due
to the positional effect of transgene integration [29,30], a
phenomenon not unique to plants [19]. However, for
both constructs, the distribution of transcript accumula-
tion data is statistically indistinguishable for either the
TEV 5'-probe (t test, P = 0.46, Insert in Fig. 4B) or the VSP
3'-probe (t test, P = 0.22, Insert in Fig. 4C). Furthermore,
the quantitative real time RT-PCR assays directed, respec-
tively, at the common 5' and 3' UTRs correlate well with
each other (r2 = 0.51, P <0.0001, data not shown). Thus,
oACHE-S and hACHE-S transcripts accumulate to similar
levels in the respective transgenic plants and it can be con-
cluded that optimization of the ACHE-S sequence did not
significantly increase transcript abundance, ruling out the
latter as an explanation for the increased AChE activity in
the oACHE-S plants. The explanation that neither tran-
scription nor stability were affected seems more likely
than the possibility that the optimization of the sequence
resulted in simultaneous but opposite changes in tran-
scription and stability (i.e. increased transcription with
reduced transcript stability and vice versa).
Optimization affects translation of the ACHE transcript
Having ruled out transcriptional and post-transcriptional
events that may affect the accumulation level and the bona
fide processing of the transcript of hACHE-S, we turned
our attention to translational events. In our design of the
optimized gene we took care not to introduce any amino
acid changes and the mature protein products are
expected to be identical. Nonetheless, our cloning proce-
dure did necessitate minor changes in the N-terminus of
the proteins, an R2G substitution in the hACHE-S
sequence and insertion of A at the same position in the
oACHE-S (Fig. 1). This region is part of the cleavable ER-
targeting signal peptide in humans [18,31] and plants
(SignalP3.0 server, [32,33] and Geyer et al, unpublished).
To rule out the possibility that these small differences may
effect the post-translational stability of the respective pro-
teins, we incubated leaf explants from representative
transgenic plants with or without cycloheximide to
inhibit cytosolic proteinsynthesis (by blocking 80S ribos-
omes) and followed the degradation of the enzyme by
assaying the residual AChE activity over a period of several
hours (Fig. 5). The half-life time of the enzyme under
these conditions is about 5 hours with no significant dif-
ferences between hACHE-S or oACHE-S plants (P = 0.2,
Fig. 5A). In the absence of cycloheximide (i.e. with, pre-
sumably, ongoing protein translation), a 20–30% loss of
AChE is observed (Fig. 5B), which may be the result of the
ex-vivo conditions of the experiments including the activa-
tion of wound-inducible proteases and depletion of the
explants' energy resources. Interestingly, under these con-
ditions that allow protein turnover, enzyme activity is lost
somewhat (but significantly) slower in oACHE-S derived
explants as compared to its loss in hACHE-S explants. This
may suggest that AChE translated from human-sequence
transcripts is replenished (resulting in greater net loss) less
efficiently than AChE translated on plant-optimized tran-
scripts.
Taken together, our results indicate that the higher levels
of recombinant protein in the oACHE-S transgenic plants
as compared to the hACHE-S plants are not due to tran-
scriptional, post-transcriptional or to post-translational
events. Rather, it appears that increased translation rates
of the oACHE-S mRNA are responsible for the fact that
AChE accumulates to higher levels in the oACHE-S plants.
Degradation of AChE proceeds at similar rates in plants  expressing the optimized and non-optimized sequences Figure 5
Degradation of AChE proceeds at similar rates in 
plants expressing the optimized and non-optimized 
sequences. Degradation was assayed by following the loss 
of enzymatic activity in leaf discs in the presence of the 
cytosolic protein synthesis inhibitor cycloheximide (A, 
+CHX) or in its absence (B). Plotted are means ± SEM of 
individual explant samples (N = 1–8). Non-linear regression 
analysis was performed using the Prism software with the 
resultant equations. oAChES + CHX: y = 103e-0.11X (R2 = 
0.78); oAChES: y = 103e-0.03X (r2 = 0.36); hAChES + CHX: y 
= 98e-0.14X (r2 = 0.6123); hAChES: y = 95e-0.04X (r2 = 0.4463). 
The differences between the regression lines obtained in the 
presence of CHX are not significant (unpaired t-test, P = 
0.195) while all other combinations are highly significant (P < 
0.0001).BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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Initiation is often considered to be the rate-limiting step
for the translation process, and the regulation of mRNA
sequences and secondary structures flanking the initiatory
AUG are considered to play critical roles [34-36]. All of
our constructs contained the same 5'-UTR (the TEV
leader), but the 5'-proximal regions of the coding
sequence were vastly different between the optimized and
the human constructs in terms of their codon usage and
GC content (Fig. 2). By in silico folding of the common 5'-
UTR and the first 150 nucleotides of the two coding
sequences (Mfold program [37]), it can be shown that in
the six most-stable putative secondary-structures pre-
dicted for hACHE-S, the initiatory AUG is found within a
relatively long and stable stretch of double helical RNA
(∆G° = 17.5 ± 0.0 kcal/mol, data not shown), while the
equivalent region of oACHE-S is predicted to be at a base
of a very short and considerably less-stable stem-loop
structure (∆G° = 6.3 ± 0.6 kcal/mol). It may therefore be
speculated, based on these hypothetical structures, that
the 5' proximal coding region plays an important role in
controlling translation initiation.
To test this hypothesis, we have swapped a 223 bp frag-
ment of the 5' proximal region between the native and
optimized constructs and created two chimeric sequences:
o-hACHE-S and h-oACHE-S (Fig. 3A), which were tran-
siently expressed in N. benthamiana leaves (Fig. 6).
Expressing  h-oACHE-S, which contained the native 5'-
proximal sequence (with the rest optimized), resulted in a
drastic and highly significant (P  <0.0001) drop in the
expression level when compared to the fully optimized
sequence, but expression level was still modestly higher
than for hACHE-S. In contrast, AChE accumulation levels
driven by the construct ohACHE-S (in which only the 5'-
proximal region of the sequence was optimized) were
only marginally higher than, and statistically not different
from, those obtained with hACHES (1.2 fold, P < 0.3, Fig.
6). Therefore, optimization of the 5'-coding region of the
human ACHE gene, representing only about 10% of the
entire sequence is necessary, but not sufficient, for
enhanced expression of the gene in plants.
Discussion
The history of molecular biology and its applications dur-
ing recent decades is inseparably linked to the ability to
express proteins in heterologous systems – i.e. the expres-
sion of a "target" protein from one species in "host" cells
of another species [1]. From a biotechnology perspective,
success in such efforts can be defined by "high-level" accu-
mulation of the bona fide target in the host. This requires
selecting the appropriate host species (and strain), defin-
ing its optimal growth conditions and/or optimizing
genetic elements that control the expression and accumu-
lation of the target. For example, expression in Escherichia
coli of mammalian AChE, a glycoprotein, results in low
yields of the unglycosylated, misfolded and destabilized
protein [16], pointing to the need for a eukaryotic expres-
sion system. The importance of determining appropriate
conditions is demonstrate by AChE of the electric ray, a
cold-adapted fish, which, when expressed in mammalian
cells, failed to accumulate if the cells were grown at 37°C,
but could accumulate if the growth temperature was low-
ered [38]. Similarly, human AChE produced in Pichia pas-
toris was poorly secreted into the medium as compared to
AChE from the snake Bungarus fasciatus [17,39], probably
because of a transcription-attenuating GC rich region
close to the 5'-end of the human coding sequence (Fig. 2)
[31,39].
Our initial attempt at expressing human AChE in trans-
genic plants was modestly succesful, based on the defini-
tion suggested above: the enzymatic activity was
indistinguishable from that of authentic human AChE,
but the level of activity was fairly low [20]. An important
factor responsible for the low observed activity in crude
extracts was the presence of the anticholinesterase glycoal-
kaloid tomatine in the transgenic host – tomato plants
[21]. However, low expression/accumulation levels of for-
eign proteins in transgenic plants have unfortunately been
the norm rather than the exception, despite an obvious,
and rather natural, bias in the literature to focus on the lat-
ter (for a comprehensive case study see Diehn et al [40]).
Optimization of the 5'-proximal region of ACHE-S is critical  but not sufficient for high expression levels Figure 6
Optimization of the 5'-proximal region of ACHE-S is 
critical but not sufficient for high expression levels. 
The following constructs were transiently expressed by A. 
tumefaciens-infiltration of N. benthamiana leaves: hACHE-S, o-
hACHE-S, h-oACHE-S, and oACHE-S. Averages of AChE activity 
of 6 replicates were normalized to that of hACHE-S to obtain 
the fold increase values (+ SEM) shown.BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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Low yields of the recombinant protein product can be the
result of limitations at every stage of gene expression,
from transcription, through transcript processing and
half-life, translation, post-translational modifications and
turnover. Several strategies have been developed to over-
come such limitations, including expression in plastids
[41,42], use of virus-assisted expression systems [43-45],
and optimizing the expression cassette to include strong
promoters, appropriate 5'- and 3'-UTR, fusing targeting
sequences, and conforming codon usage to that of plants
[40,46]. Plastid expression is precluded because AChE is a
glycoprotein and viral systems able to support the expres-
sion of >70-kDa proteins have only just become available
for testing [45]. We therefore opted to focus on optimiza-
tion of the gene sequence, which was synthesized de novo
(Fig. 1, 3A), and was introduced into the low-alkaloid spe-
cies  N. benthamiana [47], lacking appreciable anti-
cholinesterase activity (data not shown).
We present evidence for a substantial (>40 fold) increase
in the accumulation of AChE activity in soluble protein
extracts obtained from transgenic N. benthamiana plants
expressing the full length S variant of human AChE as
compared to our previously reported results concerning
the expression of the AChE core domain in tomato plants
(compare Fig. 3 and Fig 6 to Mor et al. [20] and Fletcher
et al. [21]). In order to directly assess the effects of coding
sequence optimization on the expression of the gene and
the accumulation of its product, we compared the per-
formance of the optimized gene construct (oACHE-S) to
its native counterpart (hACHE-S) in N. benthamiana by
transient expression assays (Fig. 3B) as well as in stable
transformants (Fig. 3C). We demonstrate that optimiza-
tion results in a 5 to 10 fold increase in the accumulation
of the enzyme. Our results imply that a major contribu-
tion to the successful expression presented here is due to
the optimization of the construct, although there were
species- and isoform specific effects. For example, expres-
sion in tomato plants was considerably lower than in N.
benthamiana and expression of the catalytic domain (con-
stituting all but the 40-residue long C-terminal domain)
was lower than that of AChE-S (unpublished observa-
tions). The latter may reflect the stabilizing effect of the
carboxyl-terminal peptide of the S isoform [48]. Our
results further establish that expression of AChE in N.
benthamiana appears to have been marginally, if at all,
limited by transcriptional, post-transcriptional, or post-
translational events (Fig. 3, 4, 5, 6). It stands to reason,
therefore, that enhanced translation of oACHE-S  tran-
scripts as compared to those of hACHE-S is responsible for
the better performance of the latter construct.
Without dismissing other explanations, most previous
reports suggested that limitations in expression of trans-
genes in plants are mainly due to unfavorable mRNA
metabolism, more specifically to reduced synthesis, pre-
mature polyadenylation, aberrant splicing and reduced
stability of transcripts of foreign gene in plant cells
(reviewed by Diehn et al. [40]). Indeed, the case is quite
compelling for at least one well-studied group of trans-
genes encoding the insecticidal δ-endotoxins of Bacillus
thuringiensis (B.t.). When introduced into plant nuclear
genomes, B.t. genes expressed poorly, and the dismal
expression levels correlated well with low abundance of
the full-length transcripts. A systematic and thorough
investigation into the molecular mechanisms of low B.t.
mRNA levels (and the consequential low levels of B.t. tox-
ins) by Pamela Green and co-workers, led to their conclu-
sion on the importance of "instability of mRNA as a cause
of limited expression of foreign genes" in general [13]. B.t.
genes, like many other eubacterial genes, are AT-rich and
have multiple AU-rich destabilizing sequences and AU-
rich plant polyadenylation signals in their mRNAs. All of
these factors may contribute to rapid mRNA decay
[13,40]. The eubacterial codon-usage bias towards AU-
rich codons was also concluded to contribute to mRNA
decay [13,40], although rare codons are clearly not suffi-
cient to cause transcript degradation [49]. We, like others,
observe good correlation between the transgene transcript
levels and protein accumulation levels. Nevertheless opti-
mization did not increase mature mRNA abundance (Fig.
4) and we have no evidence for aberrantly shorter mRNA
species in plants that express the non-optimized hAChE-S
construct. Furthermore, eliminating three potentially del-
eterious RNA sequences from hACHE-S did not result in
improved performance, while introducing them into
oACHE-S did not lead to reduced expression. Thus, we
conclude that mRNA metabolism is unlikely to be key ele-
ment in controlling expression of the ACHE transgene in
plants.
What could be, then, the factors that limit the expression
of the human ACHE gene in plants? In many cases of het-
erologous protein expression, the problem that "proteins
are often difficult to express outside their original con-
text," [1] can be overcome by changing codons to reflect
frequencies observed in highly expressed proteins in a par-
ticular expression system. Codon usage bias is the primary
factor in limiting heterologous gene expression in
prokaryotes [50,51], chloroplasts [52], and mammalian
cells [53,54]. Codon bias is associated with translational
bias: highly expressed genes tend to utilize a limited set of
codons and avoid the use of others, while codon prefer-
ence positively correlates with their cognate tRNA content
[1,55]. Rare codons, especially when clustered in the 5'-
coding region (as can be seen in hACHE-S, Fig. 2), can
lead to ribosome stalling, which acts to reduce elongation
rates [2], and in some cases (but evidently not the case
here) may in turn destabilize the mRNA [13].BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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Codon bias is inherently linked to a skew in the
sequence's GC content. Many of the genes whose expres-
sion was attempted in plants, including the B.t. genes, are
bacterial and highly AU-rich. Because AU-rich sequences
destabilize mRNA in plants [13], the rule of thumb was to
elevate the GC content as part of the optimization process.
At 65%, the GC content of human ACHE is particularly
high, and in specific areas, such as the 5'-proximal region,
it is 75% GC (Fig. 2). At the molecular level, the high GC
content of the 5'-proximal region may act to stabilize sec-
ondary mRNA structures, which in the context of mam-
malian cells may attenuate the transcription machinery
[31,39]. While we do not observe differences in the over-
all steady state levels of the ACHE transcript accumulating
in either oACHE-S or h-ACHE-S plants, secondary struc-
tures also affects translation initiation [56-58] and may
also have a role in controlling the translation elongation
rate [59]. By creating chimeric constructs consisting of
optimized and native human sequences we were able to
show thatthe GC-rich 5' membrane proximal region com-
prising about 10% of the gene had a pronounced inhibi-
tory effect on the expression level from the otherwise fully
optimized gene (h-oACHE-S construct, Fig. 6). Interest-
ingly, the reciprocal swap represented in o-hACHE-S
didn't significantly improve the expression when com-
pared to hACHES. This demonstrates that the optimiza-
tion of the 5'-proximal region of the coding sequence,
while critical for efficient translation, could not by itself
account for the high level of AChE accumulation seen in
oACHE-S expressing plants. Our results therefore suggest
that in plants, both translation initiation and elongation
are the most likely stages to be affected by sequence opti-
mization of the ACHE  gene. Our results also raise the
interesting speculation that while in plants the high GC
content of the gene may be a major obstacle for transla-
tion while in mammalian cells, normally growing at a
much higher ambient temperature (typically 10°C to
20°C higher) the region provides for yet another potential
checkpoint for the highly complex regulation of ACHE
gene expression in mammals [60].
Conclusion
The work presented here leads to the conclusion that
human AChE accumulation in plants is limited at the
translation stage and that this limitation is specifically
linked to its highly biased codon usage and GC content.
Changing the sequence to conform it to those that typical
of highly expressed genes in plants results in increased
translatability of the mRNA without affecting its accumu-
lation or processing. The contributions of codon-optimi-
zation and GC-content adjustment to expression
enhancement are difficult to be separately assessed, but it
is clear that both are important. While the overall GC con-
tent should be adjusted to resemble the general base com-
position of highly expressed genes of the expression host,
one should also pay particular attention to more localized
GC-content skews, revealed by the type of analysis shown
here (Fig. 6). Similarly, there is evidence to reject "across
the board" replacement of synonymous codons to the
most preferred one for each amino acid and in fact rare
codons at certain strategic points along the sequence play
an important role in functional protein synthesis whereby
pausing at such rare codons allows proper folding of the
already synthesized protein domains [61,62]. We are cur-
rently evaluating the relevance of this last point for the
ACHE gene. Additional factors, such as subcellular target-
ing of the protein product and its subunit composition
may affect the levels of its accumulation in the transgenic
host. Indeed, we have preliminary evidence demonstrat-
ing that ER retention further increases the accumulation
of some AChE variants (but not others) in stably trans-
formed plants to about 1% of total soluble protein
(Geyer, Fletcher and Mor, unpublished). Such a level of
expression allowed us to efficiently purify the enzyme and
we are currently testing its organophosphate scavenging
potential in animal models.
Methods
Codon usage bias, GC content and mRNA folding analyses
Codon frequencies were obtained from the Codon Usage
Database [63,64]. Codon usage bias was calculated
according to Sharp and Li [55]. Briefly, the mRNA
sequences encoding a group of highly expressed proteins
from the model dicotyledonous plant Arabidopsis thaliana
were selected to provide a reference for the codon usage
bias. These included the small subunit 1B of RuBisCO,
chlorophyll A/B binding protein 2, ribosomal protein L1
and L2, 40S ribosomal protein S2, S3 and S4, (accession
nos. NM_123204, NM_102733, NM_202757,
NM_201956 NM_115247, NM_115247 and
NM_125228, respectively). The relative synonymous
codon usage (RSCU = observed frequency/expected fre-
quency assuming equal usage of synonymous codons for
an amino acid), the relative codon adaptiveness (w, RSCU
normalized to the most abundant synonymous codon for
an amino acid) and the CAI values were calculated for the
human ACHE gene sequence [31] according to Sharp and
Li [55] (Fig. 2). Rare (or infrequently used) codons are
arbitrarily defined here as having w values of less than 0.8.
A moving CAI value (n  = 50) was calculated for each
codon. Similarly, the GC frequency was scored for each
base as the average of a 100-base stretch centering on the
particular base (Fig. 2). We have used the Mfold program
[37] to predict mRNA secondary structures within the first
300 bases of the mRNA (centering on the initiatory AUG).
Construction of a plant-expression vector for the human 
ACHE-S gene (hACHE-S)
Amplification of DNA was done using the Expand High
Fidelity PCR kit (Roche), unless otherwise noted. SiteBMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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directed mutagenesis was performed using the Quick-
Change kit (Stratagene). The gene encoding human
AChE-S (hACHE-S) was PCR-amplified from pACHE-E6
[48] using the primers oTM001 and oTM005 (Table 2),
cloned into pTOPOTA (Invitrogen) to yield pTM048. Site
directed mutagenesis with primers oTM109 and oTM110
was performed to remove the single NcoI site within the
gene to yield pTM180. An NgoMI-KpnI fragment was used
to replace the corresponding fragment in pTM034 [20] to
yield pTM192 and its sequence was confirmed (Fig. 3).
The expression cassette from pTM192, containing the
hACHE-S coding region behind a cauliflower mosaic virus
35S (CaMV35S) promoter and the 5'UTR of tobacco etch
virus (TEV leader) and in front of the 3'UTR of the soy-
bean vspB gene (VSP terminator), was cloned into the
binary vector pGPTV-kan as described before [20] to yield
pTM245 (Fig. 3). The binary vector pTM050 contained the
hACHE-S gene with a single-base mutation.
Construction of a plant-optimized ACHE-S gene 
(oACHE-S) and plant expression vector
The oACHE-S gene was assembled by the method of Stem-
mer et al. [65]. Briefly, 78 partially overlapping oligodeox-
yribonucleotides, collectively encoding both strands of
oACHE-S  were synthesized (Integrated DNA Technolo-
gies, Inc., Coralville, IA), ranging 3560 bases in length.
Exact lengths of the oligonucleotides were determined so
that the overlap Tm would be 60 ± 2°C. Oligonucleotides
representing three sections of the gene (bases 1–785, 786–
1333, 1334–1848, Fig. 1, 3A) were separately mixed and
Table 2: Oligonucleotides used in this study.
#N a m e 5 '  S e q u e n c e  3 '
1 TEVf CAACATATACAAAACAAACGAATCTCAAG
2 TEVr GCTATCGTTCGTAAATGGTGAAAA
3 TEVp ATTCTACTTCTATTGCAGCAAT
4 oTM001 GATATCTGCAGCCATGGCTAGGCCCCCGC
5 oTM087 GTCTGCTACCAATATGTGGACACCC
6 oTM109 CTTTGCGGAGCCACCAATGGGACCCCGTCGC
7 oTM110 GCGACGGGGTCCCATTGGTGGCTCCGCAAAG
8 oTM089 CCCACCTTGTGGGCTGTCCTCCAGG
9 oTM090 CCTGGAGGACAGCCCACAAGGTGGG
10 oTM005 GGGTACCCGCCGGGGTCACAGGTCTG
11 oTM049 GAGTGTCTTAGGTGACTTACCCAC
12 oTM125 ATTTCCATGGGAAGGCCTCCACAATGTCTCCTCCACACTCCTTCCTTG
13 oTM127 CTCTTCCACAGGGCTGTGCTCCAATCTGGCGCGCCCAATGG
14 oTM128 GCCCACAGTGGCCCAGGGACCATTGGGCGCGCCAGATT
15 oTM126 TTCAGCAAGGACAATGAGTCTCTCATCTCCAGGGCTGAGTTCTTGGCTG
16 oTM129 CCAGTGGCACAATTGGCTGGAAGATTGGCTGCCCAAGGTGCC
17 oTM130 CTTCCAGCCAATTGTGCCACTGGGCACACCACATTGTGGTCTCCCAC
18 oTM131 TCCACCGCCACCACCGGTACCGAGCTCTCAGAGGTCTGAGCA
19 oTM047 AAGATAGGTGCTCAGACCTCTGAGAGCT
20 oTM085 GATACTCACAGAAAGAGGCTACTC
21 oTM086 CAGGATACGGGGAGCTAATGCAG
22 oTM095 GCCCAATGGACCCTGGGCC
23 oTM096 GGCCCAGGGTCCATTGGGC
24 oTM097 GTTCCCCAAGTaagtGACTTGGCTGC
25 oTM098 GCAGCCAAGTCacttACTTGGGGAAC
26 oTM099 CTGGAGCACAACAgtacGTTTCTTTGGACC
27 oTM100 GGTCCAAAGAAACgtacTGTTGTGCTCCAG
28 oTM101 CCCCCAATGGtCCCTGGGCC
29 oTM102 GGCCCAGGGaCCATTGGGGG
30 oTM103 GGTTCCCCAGGTttcaGACCTGGCAG
31 oTM104 CTGCCAGGTCtgaaACCTGGGGAACC
32 oTM105 GGGGCTCAGCAatatGTTAGTCTGGACC
33 oTM106 GGTCCAGACTAACatatTGCTGAGCCCC
34 oTM165 CCATGGGACCTAGGCGCTTTCTGC
35 oTM166 GCAGAAAGCGCCTAGGTCCCATGG
36 oTM167 CCAATGGGACCTAGGAGGTTTCTCCC
37 oTM168 GGGAGAAACCTCCTAGGTCCCATTGG
38 VSPf GCTAGAGTTTGCTCCTATCTATATGTAATAAGG
39 VSPr CATTAACAAACATAGCTAATGCTCCTATTT
40 VSPp ATGCTGATATGCACTATTBMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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subjected to PCR amplification. Next, 1/20th of the PCR-
amplified mixtures were subjected to a second round of
PCR using flanking primers to yield three fragments for
the three sections. The fragments were gel-purified, cloned
into pTOPOTA (Invitrogen), to yield pTM052, pTM053
and pTM057. An AscI-SacI fragment of pTM053 was
cloned into the respective sites of pTM052 to yield
pTM075. An MfeI-KpnI fragment of pTM057 was then
cloned into pTM075 to yield pTM079, containing all
three  oACHE-S fragments. The plasmid was sequenced
and a singlebase mutation was corrected (sequence of
oACHE-S  was deposited with GenBank, accession no.
DQ140345, Fig. 3). An NcoI-KpnI fragment from pTM079
was used to replace the corresponding fragment in
pTM034, yielding the intermediate vector pTM084, and
the pGPTVkan based binary vector, pTM092 (Fig. 3).
Construction of variants of hACHE-S and oACHE-S 
genes
Alterations of specific sequences in the hACHE-S  and
oACHE-S genes were introduced by site directed mutagen-
esis as follows (for the oligonucleotides used, see Table 2).
The pea poly-A signal in pTM048 was mutated (Fig. 3)
[25] using primers oTM101 and oTM102 to yield
pTM152. The two 5'-intron splice signals present in
pTM048 were sequentially mutated by using oTM103 and
oTM104 to disrupt one signal, yielding pTM153, and then
using oTM105 with oTM106 to disrupt the other, yielding
pTM161. Similarly, the two 5'-intron splice signals were
mutated in pTM152 to yield pTM157, resulting in a
hACHE-S variant lacking all three potentially deleterious
sequences. We then replaced the NgoMI-KpnI fragment in
pTM034 with the corresponding fragment in pTM152,
pTM161, and pTM157, obtaining pTM160, pTM162, and
pTM158, respectively. Following sequence confirmation,
the expression cassette was cloned into the binary vector,
pGPTV-kan, as described above to yield hACHE-S con-
structs, pTM163 (minus poly-A), pTM166 (minus
5'intron splice sites), and pTM159 (minus poly-A and 5'-
intron splice sites).
The three potentially deleterious sequences were intro-
duced back into the oACHE-S sequence in an analogous
way. The mutagenesis oligonucleotides oTM095, oTM096
were used to recreate the poly-A signal in pTM079 to give
pTM189. An NcoI-SacI fragment was used to replace the
corresponding fragment in pTM034 to yield pTM194 and
its sequence was confirmed. The two 5'-intron splice sig-
nals were introduced into the sequence of pTM053 and
pTM057 with oligonucleotides oTM097, oTM098,
oTM099 and oTM100 yielding pTM169 and pTM148
respectively. The plasmids were sequenced and the full-
length oACHE-S coding sequence (with the splicing sig-
nals) was reassembled from an AscI-MfeI fragment of
pTM169, an MfeI-SacI fragment of pTM148, and the SacI-
AscI backbone of pTM084 by a triple-ligation cloning step,
yielding pTM172. Reintroduction of all three potentially
deleterious signals was similarly carried out yielding
pTM151. Following sequence confirmation, the expres-
sion cassettes from pTM194, pTM172, and pTM151 were
cloned into the binary vector pGPTV-kan, as described
above to yield oACHE-S  construct variants, pTM196
(+poly-A), pTM193 (+5'-intron splice sites), and pTM154
(+poly-A, +5'-intron splice sites).
Construction of mosaics of hACHE-S and oACHE-S 
genes
An AvrII restriction site was introduced into the hACHE-S
plasmid, pTM048, and the oACHE-S plasmid, pTM084
(with the respective primer pairs, oTM165 and oTM166,
and oTM167 and oTM168, see Table 2), yielding pTM241
and pTM235, respectively. Following sequence verifica-
tion, a XhoI-SacI fragment from pTM235 was cloned into
pTM084 to yield pTM238, while an NgoMI-KpnI fragment
from pTM241 was used to replace the corresponding frag-
ment in pTM034 to yield, pTM242 (Fig. 3A). The HindIII-
AvrII fragment from pTM238 was used to replace the cor-
responding fragment from pTM238, yielding pTM252.
Similarly, an AvrII-SacI fragment from pTM238 was used
to replace the corresponding fragment from pTM242, to
yield pTM253. The expression cassettes from pTM252 and
pTM253, complete with the aforementioned control ele-
ments of pTM034 were then cloned into the binary vector,
pGPTV-kan, as described above, to yield pTM256 (o-
hACHE-S) and pTM257 (h-oACHE-S), respectively.
Stable and transient transformation of Nicotiana 
benthamiana
Binary vectors containing genes of interest were electropo-
rated into Agrobacterium tumefaciens LBA4404 and were
used in the subsequent transformation of N. benthamiana
explants (>50 each) as described before [66]. Kanamycin-
resistant plants were regenerated as described [66]. Agro-
bacterium-mediated transient expression assays were con-
ducted essentially as described before [67,68]. Briefly, A.
tumefaciens cells harboring the appropriate expression vec-
tors were grown for 24 hours, harvested by centrifugation
and resuspended to culture density of 0.4 OD600 in 10 mM
MES (pH 5.5) and 200 µM acetosyringone. Test constructs
were co-expressed with the silencing suppressor protein,
p19 [68]. To this end, A. tumefaciens cells carrying each test
plasmid were mixed (1:1) with A. tumefaciens cells carry-
ing a CaMV 35S promoter-driven p19 expression vector
(kind gift of Dr. Hugh Mason). After nicking the abaxial
leaf epidermis with a needle, the bacterial suspension was
infiltrated into the leaf through a blunt tip of a 1 ml
syringe. Five days post-infection, the infiltrated-leaf tissue
was harvested and homogenized as described below.BMC Biotechnology 2007, 7:27 http://www.biomedcentral.com/1472-6750/7/27
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Biochemical and Molecular analyses
Genomic PCR was preformed on 0.1 µg total DNA iso-
lated from kanamycin resistant plants (DNeasy kit, Qia-
gen) using either primers oTM087 and oTM090 or
primers oTM126 and oTM047 to amplify hACHE-S  or
oACHE-S  respectively (Table 1). RNA blot analysis on
total leaf RNA (RNAqueous kit, Ambion) was done as
described before [20] using a digoxigenin-labeled probes
that were synthesized with primers oTM087 and oTM090
and pTM079 or pTM048 as templates.
For real-time RT-PCR analysis, total cellular RNA was pre-
pared by homogenizing 100 µg of leaf tissue in a FastRNA-
Pro-Green tube containing lysis matrix (QBiogene) in the
presence of 800 µL Lysis/Binding solution (Ambion)
using a FastPrep machine (Qbiogene). Lysates were then
processed according to manufacturer's instructions for
RNAqueous kit with the plant RNA Isolation Aid
(Ambion). Residual genomic DNA was removed using the
DNAfree system (Ambion). Yield and purity were deter-
mined spectrophotometerically and then RNA samples
were reverse transcribed (RETROscript, Ambion) using
random priming. To assess the quality of the cDNA, sam-
ples were screened by PCR with the primers oTM085 and
oTM086 specific to the N. benthamiana actin gene
(AY179605) and only those samples producing the
expected 0.36 kb fragment were set aside for further
processing (data not shown). Real-Time PCR was done as
follows using an ABI Prism 7900HT sequence detection
system (Applied Biosystems). Amplification of RNA sam-
ples (18 ng) was performed in triplicates in a 384-well
plate with primers specific to the common 5'-UTR TEV
leader and 3'UTR VSP terminator sequences (TEVf, TEVr,
VSPf and VSPr, see Table 2) and custom-made TaqMan®
FAM/MGB probes (TEVp and VSPp, Applied Biosystems).
As an endogenous reference served 18S rRNA which was
amplified using the TaqMan® eukaryotic 18S rRNA prim-
ers and FAM/MGB Probe (Applied Biosystem). Transcript
levels were quantitated using two separate standard curves
for the 18S rRNA reference and the ACHE transcript (using
sample oACHE-S-24B) and normalized (ACHE value/18S
value).
RT-PCR was also used to test for the presence of shorter,
aberrantly spliced transcripts using cDNA samples (50 ng
in a 25 µl reaction) and oTM089 and oTM049 as primers
(35 cycles). In order to amplify even very rare templates, 1
µl samples of the above PCR reactions (total new reaction
volume was 100 µl) were subjected to a second 35-cycle
round of PCR, and the products were resolved by agraose
gel electrophoresis.
To assess the ex-vivo stability of plant-expressed AChE,
leaf discs (7 mM) from seedlings were floated, abaxial side
up, in diH2O or in diH2O supplemented with 1 mM
cyclohexamide [Sigma, 69]. At the indicated time points,
leaf discs were sampled (n = 10), blotted dry, snap frozen
in liquid N2 and stored at -80°C until further analysis.
Leaf samples were homogenized in ice-cold extraction
buffer (1 M NaCl, 25 mM Tris, 0.1 mM EDTA, 10 µg/ml
leupeptin (Sigma), and 0.5% Triton X-100, pH 7.4, 3 ml
per 1 g tissue) using ceramic beads in a FastPrep machine.
Ellman cholinesterase assays using acetylthiocholine
(ATCh, Sigma) as substrate in the presence or absence of
the selective AChE inhibitor 1,5-bis(allyldimethylammo-
niumphenyl)pentan-3 one dibromide (BW, 10 µM,
Sigma) were done as described [20]. BW-inhibitable ATCh
hydrolysis rates were monitored at 405 nm for 30 min
with a SpectraMax 340PC spectrophotometer, (Molecular
Devices) and specific activity has been reported in mU/mg
protein (AChE unit definition here is, 1 µmol ATCh
hydrolyzed in 1 min at 25°C). Total soluble protein was
determined as described before [20].
Statistical analyses
Student t test for two-group comparisons was performed
with GraphPad Prism 4.0c for Macintosh (GraphPad Soft-
ware, San Diego California USA). Multi-group compari-
sons were done using the non parametric exact
permutation test with the PGD program [70] and P values
were computed based on 10 repeat blocks of 1,000 per-
mutations each.
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